267 - Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML
| Autor: | Tontsch-Grunt, U., Savarese, F., Baum, A., Scharn, D., Gerlach, D., Hofmann, M.H., Popow, J., Schweifer, N., Engelhardt, H., Musa, H., Lee, C.P., Munzert, G.M., Kraut, N. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S89-S89 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect